Latest Cost Management Strategies News

Chariot Resources reports promising high-grade lithium assays in Nigeria and advances US exploration with 32 new drilling targets, while securing strategic MOUs for financing and offtake.

RemSense Technologies reported a robust Q2 FY2026 with strong Tier-1 project deliveries worth A$1.685 million and significant progress on its ISO 27001 cybersecurity certification, underpinning its digital twin platform’s growing industrial footprint.

OM Holdings has recommissioned its Qinzhou manganese smelter in China after a four-year pause due to high power costs, signaling a strategic push to regain production capacity and market share.

Farm Pride Foods reported a robust net cash inflow of $32.56 million for the December quarter despite mounting pricing pressures and increased industry egg volumes. The company is doubling down on capital expenditure and operational improvements to sustain efficiency.

Sea Forest Limited has exceeded its breakeven target for its methane-reducing feed additive SeaFeed™, securing commitments for over 118,000 cattle and expanding commercial trials with major industry partners.

EVZ Limited has issued earnings guidance for the first half of FY2026, forecasting revenue between $60 million and $65 million and a notable rise in EBITDA, reflecting operational improvements.

KMD Brands reports a solid 7.9% increase in first quarter sales, driven by strong Kathmandu and Rip Curl performances, while managing inventory and margin pressures ahead of key seasonal trading.

Cluey Ltd has reported its strongest-ever underlying EBITDA alongside improved cash flow, while ramping up investments in AI-powered product development set to launch in 2026.

Greatland Resources reported robust production in the September 2025 quarter, delivering nearly 81,000 ounces of gold and over 3,300 tonnes of copper, while boosting its cash reserves by $175 million.

Anagenics Limited has revealed a significant 52.6% decline in revenue alongside an 83.5% increase in net loss for the financial year ended June 2025, marking a challenging period for the biotech company.

Stealth Group Holdings has reported a remarkable 130% surge in net profit for the year ended June 2025, alongside a 25% increase in revenue and a higher fully franked dividend.

Proteomics International Laboratories reported a 26% increase in losses for FY2025, driven by higher operational costs as it advances its Promarker® diagnostic pipeline. Despite an 8% rise in revenue from ordinary activities, total income slipped 2%, underscoring ongoing commercialisation challenges.